Controlled Substance
Morphine Base
Morphinum
FDA Label NDC 10191-1013
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Remedy Makers for the product Morphinum (NDC 10191-1013). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding controlled substance, indications & usage, warnings, dosage & administration, inactive ingredient, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Indications & Usage
NAUSEOUS STOMACH, POSITIONAL VERTIGO, MULTIPLE NEURITIS, OR OTHER INDICATIONS.
INDICATIONS: To be use according to standard homeopathic indications,or as prescribed by a licensed physician.
Free from yeast, wheat, corn, and soy.
Warnings
WARNING:Keep this and all medications out of reach of children.
WARNING SECTION: Use only if cap and seal are unbroken. If symptoms persist for more than 3 days, contact your physician or pharmacist. Do not take if you are pregnant or nursing a baby. Store tightly closed in a cool, dark place. Made according to The Homeopathic Pharmacopoeia of the United State by: Remedy Makers, Pomona, CA 91768
Dosage & Administration
USUAL DOSAGE: Dissolve 3 or 4 pellets in mouth or tongue as prescribed by a licensed physician. Children 2 years and younger take 1/2 the adult dose
Inactive Ingredient
80% SUCROSE / 20% LACTOSE
Package Label.Principal Display Panel
Morphinum30c (Morphinum30c)
* Please review the disclaimer below.
